Filing step-change
AUROLAB · 2026-10
Quarterly observations that moved versus the prior period in 2026-10. Facts only — not a call to act.
Narrative date 2026-10-21 · Evidence medium
Aurobindo Pharma, trading under the ticker AUROLAB, has completed a standard shift in the Indian equity market.
Raw Evidence
Source observations behind the synthesis narrative.
| Metric | Value | Trend | |
|---|---|---|---|
| GROSS_MARGIN | 80.53 % | 27.27 | ▲ |
| MARGINAL_OPERATING_LEVERAGE | 27.27 % | 12.75 | ▲ |
Cite this
Source: Samhati filing step-change for AUROLAB (2026-10). Observation: Aurobindo Pharma, trading under the ticker AUROLAB, has completed a standard shift in the Indian equity market. Evidence quality: medium. Not investment advice — no buy, sell, or hold recommendation. Full narrative (Pro): https://samhati.ai/pricing Page: https://samhati.ai/stock/aurolab/q/2026-10
Other periods